HEMATOPOIETIC/LYMPHOID CANCER
Clinical trials for HEMATOPOIETIC/LYMPHOID CANCER explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC/LYMPHOID CANCER trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC/LYMPHOID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New strategy aims to tame common virus after stem cell transplants
Disease control OngoingThis study tests a modified plan to prevent and treat cytomegalovirus (CMV) infection in people with blood cancers who have had a donor stem cell transplant. CMV is a common virus that can cause serious problems after transplant. The study involves 153 participants and looks at w…
Matched conditions: HEMATOPOIETIC/LYMPHOID CANCER
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New antibody takes on Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests a new drug called ICT01, a lab-made antibody, in 292 people with advanced cancers that have not responded to standard treatments. The drug is given alone or with another cancer drug (Keytruda). The main goals are to check safety and see if the drug ca…
Matched conditions: HEMATOPOIETIC/LYMPHOID CANCER
Phase: PHASE1, PHASE2 • Sponsor: ImCheck Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC